Aspartic Aminopeptidase Is a Novel Biomarker of Aggressive Chronic Lymphocytic Leukemia

Treatment of chronic lymphocytic leukemia has advanced substantially as our understanding of the kinase signal transduction pathways driven by the B cell receptor (BcR) has developed. Particularly, understanding the role of Bruton tyrosine kinase and phosphatidyl inositol 3 kinase delta in driving p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakodkar, Pramath, More, Sanket, András, Kinga, Papakonstantinou, Nikos, Kelly, Sharon, Makrooni, Mohammad Adib, Ortutay, Csaba, Szegezdi, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408864/
https://www.ncbi.nlm.nih.gov/pubmed/32664705
http://dx.doi.org/10.3390/cancers12071876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408864/
https://www.ncbi.nlm.nih.gov/pubmed/32664705
http://dx.doi.org/10.3390/cancers12071876

Ejemplares similares